166 related articles for article (PubMed ID: 9808546)
41. Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with TP53 mutation; a referral center experience.
Poonsombudlert K; Mott S; Miller B; Dhakal P; Snow A; Hornberg S; Yodsuwan R; Strouse C; Shaikh H; Magalhaes-Silverman M; Sutamtewagul G
Eur J Haematol; 2024 Jul; 113(1):16-23. PubMed ID: 38511425
[TBL] [Abstract][Full Text] [Related]
42. Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients?
Horowitz MM
Best Pract Res Clin Haematol; 2012 Dec; 25(4):483-6. PubMed ID: 23200546
[TBL] [Abstract][Full Text] [Related]
43. Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors.
Orozco JJ; Vo PT; Gooley TA; Haaf RL; Lundberg SJ; Hamlin DK; Wilbur DS; Matesan MC; Fisher DR; Gopal AK; Green DJ; Pagel JM; Sandmaier BM
Clin Cancer Res; 2024 Jan; 30(2):274-282. PubMed ID: 37939122
[TBL] [Abstract][Full Text] [Related]
44. Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.
Kröger N; Zabelina T; van Biezen A; Brand R; Niederwieser D; Martino R; Lim ZY; Onida F; Schmid C; Garderet L; Robin M; van Gelder M; Marks R; Symeonidis A; Kobbe G; de Witte T;
Haematologica; 2011 Feb; 96(2):291-7. PubMed ID: 20971823
[TBL] [Abstract][Full Text] [Related]
45. Effects of Total Body Irradiation on Hematopoietic Cell Transplantation Outcomes in Pediatric Acute Myeloid Leukemia with Prior Central Nervous System Involvement.
Takahashi T; Lake AJ; Wachter F; Calderon FA; Dandoy C; Keating AK
Transplant Cell Ther; 2024 May; ():. PubMed ID: 38763417
[TBL] [Abstract][Full Text] [Related]
46. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.
Zimmerman Z; Scott BL; Gopal AK; Sandmaier BM; Maloney DG; Deeg HJ
Bone Marrow Transplant; 2012 Jun; 47(6):804-9. PubMed ID: 21909142
[TBL] [Abstract][Full Text] [Related]
47. Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome.
Hitzler JK; He W; Doyle J; Cairo M; Camitta BM; Chan KW; Diaz Perez MA; Fraser C; Gross TG; Horan JT; Kennedy-Nasser AA; Kitko C; Kurtzberg J; Lehmann L; O'Brien T; Pulsipher MA; Smith FO; Zhang MJ; Eapen M; Carpenter PA;
Biol Blood Marrow Transplant; 2013 Jun; 19(6):893-7. PubMed ID: 23467128
[TBL] [Abstract][Full Text] [Related]
48. Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial.
Fuchs EJ; O'Donnell PV; Eapen M; Logan B; Antin JH; Dawson P; Devine S; Horowitz MM; Horwitz ME; Karanes C; Leifer E; Magenau JM; McGuirk JP; Morris LE; Rezvani AR; Jones RJ; Brunstein CG
Blood; 2021 Jan; 137(3):420-428. PubMed ID: 33475736
[TBL] [Abstract][Full Text] [Related]
49. Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party.
Onida F; Brand R; van Biezen A; Schaap M; von dem Borne PA; Maertens J; Beelen DW; Carreras E; Alessandrino EP; Volin L; Kuball JH; Figuera A; Sierra J; Finke J; Kröger N; de Witte T;
Haematologica; 2014 Oct; 99(10):1582-90. PubMed ID: 25085359
[TBL] [Abstract][Full Text] [Related]
50. Children with acute leukemia: a comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation.
Lin YF; Lairson DR; Chan W; Du XL; Leung KS; Kennedy-Nasser AA; Martinez CA; Heslop HE; Brenner MK; Krance RA
Pediatr Blood Cancer; 2011 Jan; 56(1):143-51. PubMed ID: 21108446
[TBL] [Abstract][Full Text] [Related]
51. Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.
Eissa H; Gooley TA; Sorror ML; Nguyen F; Scott BL; Doney K; Loeb KR; Martin PJ; Pagel JM; Radich JP; Sandmaier BM; Warren EH; Storb R; Appelbaum FR; Deeg HJ
Biol Blood Marrow Transplant; 2011 Jun; 17(6):908-15. PubMed ID: 20932924
[TBL] [Abstract][Full Text] [Related]
52. Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
Murillo-Sanjuán L; González-Vicent M; Argilés Aparicio B; Badell Serra I; Rodríguez Villa A; Uria Oficialdegui ML; López-Duarte M; Beléndez-Bieler C; Sastre Urgelles A; Sevilla Navarro J; Diaz-de-Heredia C;
Bone Marrow Transplant; 2021 May; 56(5):1213-1216. PubMed ID: 33303901
[TBL] [Abstract][Full Text] [Related]
53. OUTCOME OF ALLOGENEIC BONE MARROW TRANSPLANT FOR IRAQI PATIENTS WITH ACUTE MYELOID LEUKEMIA.
Naji AS; Gata AK; Hamodi LE; Abass M; Yousif FS
Wiad Lek; 2021; 74(9 cz 2):2247-2254. PubMed ID: 34824167
[TBL] [Abstract][Full Text] [Related]
54. Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents: an emerging entity with a poor prognosis.
Jabbour E; Ghanem H; Huang X; Ravandi F; Garcia-Manero G; O'Brien S; Faderl S; Pierce S; Choi S; Verstovsek S; Brandt M; Cortes J; Kantarjian H
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):93-7. PubMed ID: 24447728
[TBL] [Abstract][Full Text] [Related]
55. Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study.
Krishnamurti L; Neuberg DS; Sullivan KM; Kamani NR; Abraham A; Campigotto F; Zhang W; Dahdoul T; De Castro L; Parikh S; Bakshi N; Haight A; Hassell KL; Loving R; Rosenthal J; Smith SL; Smith W; Spearman M; Stevenson K; Wu CJ; Wiedl C; Waller EK; Walters MC
Am J Hematol; 2019 Apr; 94(4):446-454. PubMed ID: 30637784
[TBL] [Abstract][Full Text] [Related]
56. A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Webster JA; Yogarajah M; Zahurak M; Symons H; Dezern AE; Gojo I; Prince GT; Morrow J; Jones RJ; Smith BD; Showel M
Leuk Lymphoma; 2021 Dec; 62(13):3181-3191. PubMed ID: 34284701
[TBL] [Abstract][Full Text] [Related]
57. Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era.
Hong S; Rybicki L; Corrigan D; Hamilton BK; Sobecks R; Kalaycio M; Gerds AT; Dean RM; Hill BT; Pohlman B; Jagadeesh D; Anwer F; Majhail NS
Hematol Oncol Stem Cell Ther; 2021 Dec; 14(4):318-326. PubMed ID: 33301747
[TBL] [Abstract][Full Text] [Related]
58. Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Halaburda K; Labopin M; Mailhol A; Socié G; Craddock C; Aljurf M; Beelen D; Cornelissen JJ; Bourhis JH; Labussière-Wallet H; Blaise D; Gedde-Dahl T; Gilleece M; Yakoub-Agha I; Mufti G; Esteve J; Mohty M; Nagler A
Haematologica; 2020 Jun; 105(6):1723-1730. PubMed ID: 31439677
[TBL] [Abstract][Full Text] [Related]
59. Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma.
Raiola A; Dominietto A; Varaldo R; Ghiso A; Galaverna F; Bramanti S; Todisco E; Sarina B; Giordano L; Ibatici A; Santoro A; Clavio M; Bacigalupo A; Castagna L
Bone Marrow Transplant; 2014 Feb; 49(2):190-4. PubMed ID: 24185585
[TBL] [Abstract][Full Text] [Related]
60. Current status of allogeneic hematopoietic cell transplantation for MDS.
Xu F; Deeg HJ
Curr Pharm Des; 2012; 18(22):3215-21. PubMed ID: 22571701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
